Redmile Group, LLC, Director, 10% Owner at FATE THERAPEUTICS INC (FATE), bought 654,970 shares at $85.50 ($56.0M) on 2021-01-08, disclosed to the SEC on 2021-01-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.50 | 327,485 | $28.0M | 50.0% |
| 2 | $85.50 | 327,485 | $28.0M | 50.0% |
| Total | $85.50 avg | 654,970 | $56.0M | 100% |
| Filing → |
| FATE | BUY | 2023-12-28 | $332K | — | Filing → |
| IGMS | BUY | 2023-07-03 | $1.5M | — | Filing → |
| IGMS | SELL | 2023-07-03 | $1.5M | — | Filing → |